Cargando…

Kynurenine Pathway Metabolites as Biomarkers in Alzheimer's Disease

Alzheimer's disease (AD) is a progressive neurodegenerative disorder that deteriorates cognitive function. Patients with AD generally exhibit neuroinflammation, elevated beta-amyloid (Aβ), tau phosphorylation (p-tau), and other pathological changes in the brain. The kynurenine pathway (KP) and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Yuqing, Xie, Shan, He, Yanyun, Xu, Manru, Qiao, Xi, Zhu, Yue, Wu, Wenbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791723/ https://www.ncbi.nlm.nih.gov/pubmed/35096208 http://dx.doi.org/10.1155/2022/9484217

Ejemplares similares

Kynurenine Pathway Metabolites as Biomarkers for Amyotrophic Lateral Sclerosis
por: Tan, Vanessa X., et al.
Publicado: (2019)

Kynurenine Pathway Metabolites as Potential Biomarkers in Chronic Pain
por: Auyeung, Andrew, et al.
Publicado: (2023)

Kynurenine pathway metabolites in migraine
por: Nicoletti, Ferdinando
Publicado: (2015)

Kynurenine Pathway Metabolites as Potential Clinical Biomarkers in Coronary Artery Disease
por: Gáspár, Renáta, et al.
Publicado: (2022)

Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington's disease
por: Rodrigues, Filipe B., et al.
Publicado: (2021)

Kynurenine Pathway Metabolites in Humans: Disease and Healthy States
por: Chen, Yiquan, et al.
Publicado: (2009)

Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer’s disease
por: Chatterjee, Pratishtha, et al.
Publicado: (2019)

O066. Kynurenine pathway metabolites in cluster headache
por: Curto, Martina, et al.
Publicado: (2015)

Electrochemical Determination of Kynurenine Pathway Metabolites—Challenges and Perspectives
por: Sadok, Ilona, et al.
Publicado: (2021)

Early Life Stress and the Fate of Kynurenine Pathway Metabolites
por: Coplan, Jeremy D., et al.
Publicado: (2021)

Measurement of kynurenine pathway metabolites by tandem mass spectrometry
por: Abusoglu, Sedat, et al.
Publicado: (2023)

Kynurenines, neurodegeneration and Alzheimer’s disease
por: Kincses, Zsigmond Tamas, et al.
Publicado: (2010)

Kynurenine pathway metabolites are associated with gray matter volume in subjects with schizophrenia
por: Zhou, Sumiao, et al.
Publicado: (2022)

Hypoxia and the Kynurenine Pathway: Implications and Therapeutic Prospects in Alzheimer's Disease
por: Adeyemi, Oluyomi Stephen, et al.
Publicado: (2021)

Altered kynurenine pathway metabolites in serum of chronic migraine patients
por: Curto, Martina, et al.
Publicado: (2016)

The impact of bariatric surgery on serum tryptophan–kynurenine pathway metabolites
por: Yeung, Kai Tai Derek, et al.
Publicado: (2022)

Dietary Kynurenine Pathway Metabolites—Source, Fate, and Chromatographic Determinations
por: Sadok, Ilona, et al.
Publicado: (2023)

Expression of Tryptophan 2,3-Dioxygenase and Production of Kynurenine Pathway Metabolites in Triple Transgenic Mice and Human Alzheimer's Disease Brain
por: Wu, Wei, et al.
Publicado: (2013)

Dynamic changes in metabolites of the kynurenine pathway in Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease: A systematic Review and meta-analysis
por: Fathi, Mobina, et al.
Publicado: (2022)

Age‐ and disease‐specific changes of the kynurenine pathway in Parkinson’s and Alzheimer’s disease
por: Sorgdrager, Freek J. H., et al.
Publicado: (2019)

The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors
por: Hughes, Tamera D., et al.
Publicado: (2022)

Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic Pathway
por: Tanaka, Masaru, et al.
Publicado: (2021)

Kynurenine Pathway Metabolites in the Blood and Cerebrospinal Fluid Are Associated with Human Aging
por: Solvang, Stein-Erik H., et al.
Publicado: (2022)

Kynurenine pathway metabolites and therapeutic response to olanzapine in female patients with schizophrenia: A longitudinal study
por: Guan, Xiaoni, et al.
Publicado: (2022)

Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer’s disease
por: Whiley, Luke, et al.
Publicado: (2021)

IDO and Kynurenine Metabolites in Peripheral and CNS Disorders
por: Huang, Yi-Shu, et al.
Publicado: (2020)

The kynurenine pathway in Alzheimer’s disease: a meta-analysis of central and peripheral levels
por: Fernandes, Brisa S., et al.
Publicado: (2023)

Kynurenine pathway metabolites selectively associate with impaired associative memory function in depression
por: Chirico, Margherita, et al.
Publicado: (2020)

The Kynurenine Pathway Metabolites in Cord Blood Positively Correlate With Early Childhood Adiposity
por: Tan, Karen Mei-Ling, et al.
Publicado: (2022)

Dynamic changes in kynurenine pathway metabolites in multiple sclerosis: A systematic review
por: Fathi, Mobina, et al.
Publicado: (2022)

Kynurenine pathway in kidney diseases
por: Zakrocka, Izabela, et al.
Publicado: (2021)

Searching for Peripheral Biomarkers in Neurodegenerative Diseases: The Tryptophan-Kynurenine Metabolic Pathway
por: Török, Nóra, et al.
Publicado: (2020)

Modulation of Enzyme Activity in the Kynurenine Pathway by Kynurenine Monooxygenase Inhibition
por: Phillips, Robert S., et al.
Publicado: (2019)

Potential of kynurenine metabolites in drug development against neurodegenerative diseases
por: Kubicova, Lenka, et al.
Publicado: (2020)

Resistance Exercise Reduces Kynurenine Pathway Metabolites in Breast Cancer Patients Undergoing Radiotherapy
por: Zimmer, Philipp, et al.
Publicado: (2019)

A novel, robust method for quantification of multiple kynurenine pathway metabolites in the cerebrospinal fluid
por: Schwieler, Lilly, et al.
Publicado: (2020)

The association of kynurenine pathway metabolites with symptom severity and clinical features of bipolar disorder: An overview
por: Bartoli, Francesco, et al.
Publicado: (2022)

Kynurenine Metabolites and Migraine: Experimental Studies and Therapeutic Perspectives
por: Fejes, Annamária, et al.
Publicado: (2011)

Kynurenine pathway metabolites predict subclinical atherosclerotic disease and new cardiovascular events in chronic kidney disease
por: Benitez, Trista, et al.
Publicado: (2022)

Kynurenine pathway metabolism and neuroinflammatory disease
por: Braidy, Nady, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_73ra57dcfm47acdi1b7d8fjiia